For the rapid detection of Alzheimer’s Disease in blood. Shimadzu recently developed the Amyloid Mass Spectrometry (MS) Service — a new simple, low-cost blood test for early screening of amyloid-positive subjects. This method enables early and accurate detection of amyloid deposition in the brain with an easy-to-acquire blood sample. Unlike conventional methods, Shimadzu’s new test is minimally invasive, cost-effective and suitable for large-scale deployment. It is currently the only blood test capable of detecting abnormal amyloid-beta deposition in the brain with 90% accuracy.
Shimadzu’s Amyloid MS Service offers:
Shimadzu has built an efficient process for analyzing samples: